JavaScript is disabled in your browser. Please enable JavaScript to view this website.

MYC

GeneName

MYC

Summary

MYC, also known as c Myc or Myc protein, is a 51 kDa transcription factor that plays a central role in regulating gene expression, cell growth, and proliferation. It is primarily located in the nucleus and nucleolus, where it forms complexes with other proteins, such as Max, to bind to specific DNA sequences, particularly in core promoter regions. MYC is involved in various biological processes including chromatin remodelling, cell cycle regulation, and responses to cellular stressors. It is essential for the transcriptional regulation of genes associated with cell division, apoptosis, and differentiation, impacting a wide range of tissues and cell types.

Importance

MYC is relevant to: - Cancer research due to its role as an oncogene, where its dysregulation is implicated in various malignancies - Stem cell biology as it regulates self-renewal and differentiation - Developmental biology through its involvement in cellular proliferation and differentiation processes - Response to environmental stressors, such as hypoxia and xenobiotics, highlighting its importance in cellular adaptation mechanisms

Top Products

For researchers investigating MYC, we highly recommend the Anti-c-Myc antibody [Y69] - ChIP Grade (ab32072). This top-selling recombinant antibody has garnered an impressive 1629 citations, reflecting its strong reputation in the field. It has been validated in knockout models and is suitable for a wide range of applications, including Western blotting (WB), immunocytochemistry (ICC), immunohistochemistry (IHC), immunoprecipitation (IP), chromatin immunoprecipitation (ChIP), and flow cytometry (FC). Its versatility and reliability make it an excellent choice for those studying MYC. The Recombinant Human c-Myc protein (Tagged) ELISA Kit (ab235798) is an excellent option for researchers looking to study c-Myc in their experiments.

Abcam Product Citation Summary

The data indicates a significant focus on the MYC gene in various cancer contexts, particularly in human colorectal cancer, glioblastoma, and leukemia. The use of Abcam antibodies for MYC detection spans multiple applications, predominantly Western blotting, highlighting its importance in studying cancer biology and related pathways such as Wnt/β-catenin signalling. Additionally, MYC's role in stemness and cell proliferation is frequently investigated across different species, including human and mouse models.

Abcam Product Citation Table

ab17355
Mouse
WB
Effects of CR treatment
32425787
ab19312
Human
WB
PIK3CA mutation related signaling
29970892
ab32
Human
WB
CD133+ cells
25551472
ab32
Human
WB
Wnt/β-catenin signaling
22032476
ab32
Mouse
WB, IHC-IF
Interaction of RalA with the exocyst complex
31201267
ab32
Human
WB
Cell cycle regulation
24391510
ab32072
Mouse
WB
ES cell extracts
22860051
ab32072
Mouse
ICC-IF
B cell stimulation
25680807
ab32072
Human
WB, ICC-IF
Doxycycline treated U2OSTet-On cells
27460974
ab32072
Human
WB, ICC-IF
MYC binding affinity to target genes
27460974
ab32072
Human
WB
SLIT2/ROBO1 axis-mediated Warburg effect
29523788
ab32072
Human
WB
Wnt/β-catenin pathway
27821172
ab32072
Human
WB
Wnt/β-catenin pathway
27821172
ab32072
Human
WB, IHC
Positive regulatory loop involving Sox2 and Wnt/β-catenin
27821172
ab32072
Human
IF, IHC
ALK + ALCL tumor cells
27821172
ab32072
Human
WB, IHC
Tumor growth rates
27821172
ab32072
Human
WB
Wnt/β-catenin signaling pathway
29343267
ab32072
Mouse
WB
Leukemia lncRNAs
28875933
ab32072
Human
WB
Hematopoietic function
28827748
ab32072
Mouse
WB
Hematopoietic injury
28827748
ab32072
Human
WB
KRAS-mutant colorectal cancer
28173629
ab32072
Human
WB
Stemness and self-renewal
28100038
ab32072
Human
WB
TRIM8 knockdown effects
28100038
ab32072
Human
WB
GBM stemness
28100038
ab32072
Human
IHC
Colorectal cancer tissue
27619912
ab32072
Human
WB
Apoptosis-related protein alterations
27729033
ab32072
Human
WB
OSCC cells
31440468
ab32072
Human
WB
Leukemia
27741509
ab32072
Human
WB
Breast cancer
31897227
ab32072
Mouse
WB
Liver proliferation
31488102
ab32072
Mouse
WB
Hepatocyte damage
31488102
ab32072
Human
WB
Cancer
32316188
ab32072
Human
WB
c-Myc stability
32316188
ab32072
Human
WB, IHC
Ribosomal protein effects
32316188
ab32072
Human
WB
Antitumor effect of MID1IP1 depletion
32316188
ab32072
Human
WB
Gastric cancer cell lines
32090087
ab32072
Human
WB
Wnt/β-catenin pathway
31854447
ab32072
Human
WB
Cell proliferation
32099528
ab32072
Human
WB
Interaction between CDK5 and MYC
31496920
ab32072
Human
WB
Effects of Dinaciclib treatment
31496920
ab32072
Human
WB
Effects of Artemisinin on Wnt/β-catenin signaling pathway
32657048
ab32072
Human
WB
Effects of Artemisinin on cell proliferation and metastasis
32657048
ab32072
Human
WB
Wnt/β-catenin pathway
31733028
ab32072
Mouse
WB
Effect of DFX on stemness in miPS cells
30717462
ab32072
Human
WB
Spherogenicity
30717462
ab32072
Human
IHC
Triple-negative breast cancer
32034133
ab32072
Human
WB
HGC-27 cells
27911852
ab32072
Human
WB
Leukemia
27741509
ab32072
Human
WB
Effects of NBT on cell growth and cycle
31380287
ab32072
Human
WB
Prostate cancer
25869206
ab32072
Human
WB
Overcoming idelalisib resistance
28178345
ab32072
Human
WB
Cell proliferation and invasion
32192213
ab32072
Mouse
WB
Alveogenesis during pregnancy
29051494
ab32072
Human
WB
Effects of EGCG
29475441
ab32072
Mouse
WB
Embryonic fibroblasts
32286286
ab32072
Mouse
WB
Skin lesions
29190822
ab32072
Mouse
IHC-IF
Embryonic stem cells and chimaeras
26586221
ab32072
Human
IHC
Fallopian tube epithelium
27492892
ab32072
Human
WB
Mitotic arrest
29987118
ab32072
Human
WB
Multiple myeloma cells
30315240
ab32072
Human
WB
Colorectal carcinoma cells
31783811
ab32072
Human
WB
Tumorigenicity
31953400
ab32072
Human
WB
MYC-dependent mechanism of BRN2 induction
31953400
ab32072
Human
WB, IHC
HPV-related oncogenesis
35228537
ab32072
Human
WB
Aerobic glycolysis
35568711
ab32072
Human
WB
Cervical cancer development
30356100
ab32072
Human
WB
SUMOylation
31285264
ab32072
Human
WB
SUMO2/3-modified proteins
31285264
ab32072
Mouse
WB
Leukemia
27741509
ab32072
Human
WB
Hepatic reprogramming
36068222

Domain

The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.

Function

Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed:24940000, PubMed:25956029). Activates the transcription of growth-related genes (PubMed:24940000, PubMed:25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed:24940000, PubMed:25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808).

Involvement in disease

A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1.

Burkitt lymphoma

BL

A form of undifferentiated malignant lymphoma commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass.

None

The gene represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving MYC are usually found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or t(2;8) which juxtapose MYC to one of the heavy or light chain immunoglobulin gene loci.

Post-translational modifications

Phosphorylated by PRKDC (PubMed:1597196). Phosphorylation at Ser-344 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-77 by CDK2 prevents Ras-induced senescence (PubMed:19966300, PubMed:20713526). Phosphorylated at Ser-77 by DYRK2; this primes the protein for subsequent phosphorylation by GSK3B at Thr-73 (PubMed:22307329). Phosphorylation at Thr-73 and Ser-77 by GSK3 is required for ubiquitination and degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:8386367). Dephosphorylation at Ser-77 by protein phosphatase 2A (PPP2CA) promotes its degradation; interaction with PPP2CA is enhanced by AMBRA1 (PubMed:25438055, PubMed:25803737).

Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-73 and Ser-77, leading to its degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:25775507). In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation (PubMed:17558397, PubMed:17873522). In the nucleolus, however, ubiquitination is not counteracted by USP28 but by USP36, due to the lack of interaction between isoform 3 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus (PubMed:17558397, PubMed:25775507). Also polyubiquitinated by the DCX(TRPC4AP) complex (PubMed:20551172, PubMed:29779948). Ubiquitinated by UBR5 when not forming a heterodimer with another bHLH protein, leading to its degradation: UBR5 recognizes and binds a degron that is only available upon heterodimer dissociation (PubMed:33208877, PubMed:37478862). Ubiquitinated by TRIM6 in a phosphorylation-independent manner (By similarity).

Cellular localization

Alternative names

BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39

swissprot:P01106 omim:164850 omim:164840 omim:190080 entrezGene:4613 entrezGene:4610 entrezGene:4609 swissprot:P12524 swissprot:P04198

Other research areas